Blog

Topical Ocular Formulation Using Cannabinoids For Glaucoma Under Development

From ASCRS EyeWorld Weekly Update March 31, 2017 Voume 22, Number 13 A topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinate (THCVHS), a prodrug of THC, will be further developed in an agreement between Nanomerics (London) and NEMUS Bioscience (Costa Mesa, California). Tetrahydrocannabinol-valine-hemisuccinate is an active component of the drug candidate NB1111 (NEMUS Bioscience), which is under development…
Read more

When LDL Goes Down, Do Cataracts Go Up?

From Review of Ophthalmology www.reviewofophthalmology.com Volume XXIV No. 3 March 2017 Excerpts: Researchers in a study recently published in the Journal of the American College of Cardiology aimed at evaluating the safety of the cholesterol-lowering drug alirocumab were relieved to find the drug didn’t induce an unusual number of neurological or neurocognitive events, but were…
Read more

Still Trailblazing at 91 Thanks to Glaucoma Surgery

Written by: Cheryl terHorst Reviewed by: Anne Louise Coleman MD PhD, Andrew George Iwach, MD, Michele C Lim MD, Rebecca J Taylor MD Adapted from an aao.org article Glaucoma: “The Sneak Thief of Sight” Ernest sought help from an ophthalmologist, a physician who specializes in medical and surgical eye care, who diagnosed him with the eye disease glaucoma. Glaucoma is a chronic eye…
Read more

Electronic glasses auto-focus on what you’re looking at

A distance meter adjusts the glycerine-based lenses in just 14 milliseconds. Written by: Steve Dent, @stevetdent    01.30.17 in Wearables They're not very pretty, but prototype eyeglasses from University of Utah scientists could make progressive lenses obsolete for older people. Using electronically activated lenses and infrared distance meters, they can focus automatically on whatever you're looking at, whether it's far…
Read more